Bleo-cell -EU (Bleomycin Vials) 15iu

Bleo-cell -EU (Bleomycin 15iu) is an injectable vial used in chemotherapy regimens. This generic formulation is manufactured by Stada Pharm in Germany. It is commonly prescribed for certain cancers and other conditions as directed by a healthcare provider.

Strength

15iu

Manufacturer / TM Owner

Stada Pharm

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Bleomycin 15iu is primarily used in chemotherapy to treat various cancers, including Hodgkin lymphoma and testicular cancer. It may also be used for other conditions as determined by a physician. This medication works by interfering with cancer cell growth. Always consult a healthcare professional for personalized treatment plans.

Side Effects

Bleomycin 15iu is designed to target rapidly dividing cells, which can help reduce the spread of cancer. Patients may experience effects such as nausea or fatigue during treatment. Skin changes, such as darkening or rash, are also possible. These effects vary by individual and should be monitored by a healthcare provider.

Precautions & Warnings

Bleomycin 15iu should be handled with care and administered by a qualified healthcare professional. Patients with lung conditions or a history of smoking may need special monitoring. Keep vials stored as directed and away from children. Report any unusual symptoms to a doctor promptly.

Avoid Interactions

Bleomycin 15iu may interact with other medications, including those that affect the liver or lungs. Alcohol and certain supplements could influence its effects. Always inform your healthcare provider about all medications and supplements you are taking. Regular monitoring may be required during treatment.

Frequently Asked Questions

Bleo-cell -EU (Bleomycin 15iu) is used in chemotherapy for certain cancers, such as Hodgkin lymphoma and testicular cancer.

This medication is given as an injection by a healthcare professional, typically in a clinical setting.

Common effects may include nausea, fatigue, or skin changes. Serious side effects should be reported to a doctor.

Prescription medications like Bleo-cell -EU require a valid prescription and are not available for direct purchase online.

Bleo-cell -EU contains Bleomycin, which is a generic chemotherapy agent.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.